Percent CD56+ cells in each sample determined by FACS
Day . | Cells . | UCB sample . | ||||
---|---|---|---|---|---|---|
1 . | 2 . | 3 . | 4 . | 5 . | ||
0 | UCB/ACF | 0 | 0 | 0 | 0 | 0 |
UCB/CD34+ | 0 | 0 | 0 | 0 | 0 | |
5 | UCB/ACF | 14 | 23 | 24 | 27 | 20 |
UCB/CD34+ | 9 | 2 | 7 | 5 | 4 | |
10 | UCB/ACF | 43 | 49 | 48 | 32 | 50 |
UCB/CD34+ | 21 | 31 | 24 | 14 | 16 | |
15 | UCB/ACF | 80 | 84 | 86 | 70 | 87 |
UCB/CD34+ | 45 | 31 | 40 | 39 | 37 | |
20 | UCB/ACF | 99 | 100 | 99 | 98 | 99 |
UCB/CD34+ | 84 | 69 | 84 | 80 | 82 | |
30 | UCB/ACF | 100 | 100 | 99 | 100 | 100 |
UCB/CD34+ | 99 | 90 | 97 | 97 | 98 |
Day . | Cells . | UCB sample . | ||||
---|---|---|---|---|---|---|
1 . | 2 . | 3 . | 4 . | 5 . | ||
0 | UCB/ACF | 0 | 0 | 0 | 0 | 0 |
UCB/CD34+ | 0 | 0 | 0 | 0 | 0 | |
5 | UCB/ACF | 14 | 23 | 24 | 27 | 20 |
UCB/CD34+ | 9 | 2 | 7 | 5 | 4 | |
10 | UCB/ACF | 43 | 49 | 48 | 32 | 50 |
UCB/CD34+ | 21 | 31 | 24 | 14 | 16 | |
15 | UCB/ACF | 80 | 84 | 86 | 70 | 87 |
UCB/CD34+ | 45 | 31 | 40 | 39 | 37 | |
20 | UCB/ACF | 99 | 100 | 99 | 98 | 99 |
UCB/CD34+ | 84 | 69 | 84 | 80 | 82 | |
30 | UCB/ACF | 100 | 100 | 99 | 100 | 100 |
UCB/CD34+ | 99 | 90 | 97 | 97 | 98 |